SCHEMBL30759563

SCHEMBL30759563

CCOC(=O)c1nn(-c2ccccn2)c2c1CCc1cc(OC)c(Br)cc1-2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.44
▸ HPGD P15428 3/20 0.43
▸ TP53 P04637 2/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ CCNA2 P20248 4/20 0.43
▸ CDK2 P24941 4/20 0.43
▸ CCNA1 P78396 4/20 0.43
▸ HTT P42858 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ LMNA P02545 2/20 0.42
▸ CDK4 P11802 1/20 0.42
▸ CCND3 P30281 1/20 0.42
▸ CDK6 Q00534 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ KDM4E B2RXH2 5/20 0.41
▸ MAPT P10636 5/20 0.41
▸ GAA P10253 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27123712 1.00 ALDH1A1 (0.44) ALDH1A1HPGDTP53NPC1RAB9A
SCHEMBL27123909 0.89 CCNA2 (0.42) ALDH1A1HPGDTP53CCNA2CDK2
SCHEMBL30759548 0.88 CCNA2 (0.45) ALDH1A1HPGDCCNA2CDK2CCNA1
SCHEMBL27123716 0.88 CCNA2 (0.45) ALDH1A1HPGDCCNA2CDK2CCNA1
SCHEMBL30759596 0.86 ALDH1A1 (0.46) ALDH1A1HPGDTP53NPC1RAB9A
SCHEMBL27120696 0.86 ALDH1A1 (0.46) ALDH1A1HPGDTP53NPC1RAB9A
SCHEMBL12046658 0.84 PDE4B (0.45) ALDH1A1HPGDTP53CCNA2CDK2
SCHEMBL12046673 0.83 CCNA2 (0.47) ALDH1A1HPGDTP53NPC1CCNA2
SCHEMBL30759580 0.82 CCNA2 (0.47) ALDH1A1HPGDTP53CCNA2CDK2
SCHEMBL27122940 0.82 CCNA2 (0.47) ALDH1A1HPGDTP53CCNA2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260008783-A1 MODULATORS OF FSHR AND USES THEREOF GEDEON RICHTER PLC (HU) 2026-01-08 — — US disclosed
EP-4577206-A2 NOVEL MODULATORS OF FSHR AND USES THEREOF Celmatix Inc. (US) 2025-07-02 — — EP disclosed
WO-2024044778-A2 NOVEL MODULATORS OF FSHR AND USES THEREOF CELMATIX INC. (US) 2024-02-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260008783-A1 MODULATORS OF FSHR AND USES THEREOF FSHR, GNRHR, LHCGR ALDH1A1 3704/4885HPGD 3529/4885TP53 4329/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback